Skip to content
International Infusion logo
Asset Manager

Updated:

International Infusion

Infusion 51a is an impact-focused investment fund on a mission to invest in, develop, and advance world-changing innovation. Initially, it seeks disruptive...

Overview

Infusion 51a is an impact-focused investment fund on a mission to invest in, develop, and advance world-changing innovation. Initially, it seeks disruptive precision-based opportunities within the life sciences. Nestled in the heart of the US research triangle in North Carolina, it is dedicated to fostering the advancement of groundbreaking health solutions worldwide. Since 2015, the fund has been allocating both financial and human capital into vetted opportunities with the potential to disrupt the life-science ecosystem.

General information

Firm type

Generalist

Year founded

2009

Location

Region

North America

Country

United States

City

Research Triangle

Corporate office

Chicago, IL, United States

Principals

Jeff Stephens

General Partner

Scott VanderMeer

MBA, General Partner

Chirag Patel

Director of Technology

Brett Logan

JD, Securities Counsel

Krishn Patel

Director of Data Collection

Todd Smith

MBA, Chief Commercial Officer

Monica Coleman

CPA, Finance Consultant

Mehrab Ajalli

Director of Strategic Growth in the MENA Region

Sector focus

Life SciencesHealthcare

Frequently asked questions

What investment stages does International Infusion target?

The firm's strategy covers seed and early-stage venture, expansion and late-stage growth, management buyouts, PIPEs, recapitalizations, reorganizations, and turnarounds. It also pursues pre-IPO and private-to-public hybrid transactions. This lifecycle-agnostic approach is unusual — most managers specialize in either venture or distressed, but International Infusion operates across both extremes.

Is International Infusion a venture capital firm or a private equity firm?

It is neither exclusively. The firm's mandate includes venture, growth, buyouts, and distressed situations, making it closer to a hybrid or merchant-banking model. Its inclusion of PIPEs, restructurings, and pre-IPO hybrids places it outside conventional fund categories.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Generalist profiles